OverviewAbout Lung Cancer Screening
Low-dose CT (LDCT) lung cancer screening detects lung cancer early in high-risk adults. Early detection significantly improves survival rates, especially at Stage I, versus late-stage diagnosis.
If you are between the ages 50 and 80 and have been smoking tobacco at least one pack a day for at least 20 years, BOOK an appointment today to be checked for lung cancer and COPD.
Lung cancer screening using low-dose computed tomography (LDCT) is an essential tool for early detection of lung cancer in high-risk individuals. Here's what you need to know:
Indication and Eligibility
Lung cancer screening is recommended for adults who meet the following criteria:
- Age: 50 to 80 years old
- Smoking history: At least a 20 pack-year history (equivalent to smoking 1 pack per day for 20 years or two packs per day for 10 years)
- Current smokers or those who have quit within the past 15 years.
Screening Effectiveness
- Number needed to screen: Approximately 320 high-risk individuals must be screened over five years to prevent one lung cancer death.
- Early detection benefit: When lung cancer is detected at an early stage, the five-year survival rate can be as high as 59%, compared to only 6% for late-stage diagnosis.
False Positive Rate
The false positive rate for lung cancer screening varies:
- Initial screening: About 12-14% of initial screenings may result in a false positive.
- Subsequent annual screenings: The false positive rate drops to 6% for continued annual screening scans.
- It's important to note that most positive results are false positives. 95% of abnormal LDCT results are false positives.
Impact on Survival Rate
Lung cancer screening has shown significant improvements in long-term survival:
- 20-year survival rate: Patients diagnosed with lung cancer through LDCT screening have a 20-year survival rate of 81%.
- Stage I survival: For those diagnosed with stage I lung cancer through screening, the 20-year survival rate increases to 87%.
- Early-stage detection: 81% of lung cancers detected through screening are found at stage I, when treatment is most effective.